Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-ergocryptine.
- [Washington, D.C., 1970]
- v.
[Reprinted from Journal of National Cancer Institute, v.45, no.6, Dec. 1970]. CRDP Program Historic Shelflist record.